INTRODUCTION: @entity43 is one of the most common gynecologic @entity5 and the fifth most frequent cause of @entity5 in @entity1 . @entity43 affects @entity1 65 years of age and older more frequently than younger @entity1 . MATERIAL AND METHODS: Four young @entity1 with @entity43 were treated at the Institute of Oncology in Sremska Kamenica, Serbia and Montenegro, in the period 1981-2000. The median age at diagnosis was 17.3 years. Final histopathological findings revealed @entity7157 , either mucinous or serous. The stage of the disease was established using International Federation of Gynecology-Obstetrics (FIGO) Calssification. Spread of the disease dictated the extent of operation and post-operative chemotherapy. @entity1 were strictly followed-up at the Institute. RESULTS: The first two @entity1 underwent unilateral adnexectomy as initial treatment. Final histopathological examination revealed @entity43 , stage IIIa and IIb. Total hysterectomy with unilateral adnexectomy and total omentectomy were performed in both @entity1 as second treatment with chemotherapy, according to the @entity900 / @entity3003 and @entity786 (CP) protocol following surgery. Another two @entity1 underwent total hysterectomy with bilateral adnexectomy and total omentectomy as initial treatment with chemotherapy, CP protocol, following surgery. Both @entity1 had stage IIc. Despite treatment, in two @entity1 with stage IIIa and IIc, @entity3 were diagnosed. In 2 @entity1 survival was over five years. One @entity1 lived less than 3 years, and one less than 4 years. DISCUSSION: @entity43 are difficult to diagnose at early stage. Histologic confirmation of the diagnosis, surgical staging, and aggressive surgical debulking, when possible, are all part of the initial evaluation and treatment. In most cases, surgery is followed by chemotherapy. The risk increases from 15.7 to 54 per 100,000 in the age group 40-79 years. Our study included 4 @entity1 , medium age 17.3, with @entity43 which warns us to think twice when we get an adolescent @entity1 with an @entity4134 . CONCLUSION: Advancing age, the major risk factor for development of @entity43 is, of course, unalterable. We investigated 4 @entity1 medium age 17.3 years, with @entity43 . Pelvic masses found in @entity1 of reproductive age, must also be evaluated preoperatively to determine the probability of @entity5 .

[ XXXX --a @entity5 sparing no age group].

@entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian epithelial carcinoma', 'ovarian carcinoma', 'Ovarian epithelial carcinoma', 'Ovarian carcinomas', 'an epithelial ovarian carcinoma', 'epithelial ovarian carcinoma', 'Ovarian cancer'] @entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer death', 'malignancy', 'malignancies'] @entity3003 :: ('MESH:D016190', 'Chemical') :: ['Carboplatin'] @entity900 :: ('MESH:D002945', 'Chemical') :: ['Cisplatin'] @entity786 :: ('MESH:D003520', 'Chemical') :: ['Cyclophos-phamide'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastases'] @entity4134 :: ('MESH:D000292', 'Disease') :: ['adnexal mass'] @entity7157 :: ('MESH:D003536', 'Disease') :: ['cystadenocarcinoma']
@entity43 :: (MESH:D010051,Disease) :: ['Ovarian epithelial carcinoma']
